Condition: Hypertension · Vascular Diseases · Cardiovascular Diseases · Sponsor: Medtronic Vascular
The purpose of the Spyral InSight Early Clinical Feasibility Study is to characterize the physiological response to renal nerve stimulation (RNS) in humans prior to and post renal denervation.
This description comes directly from the study's public registry record.
Sjors Wijnands · +31 6 1113 5502 · sjors.wijnands@medtronic.com
Marianne Wanten · +31 613703414 · marianne.wanten@medtronic.com
Always discuss trial participation with your own doctor first.
| Hippokration General Hospital of Athens | Athens, Greece | Recruiting |
| University Hospital Galway | Galway, Ireland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07013929